Volpara Health Technologies Ltd (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$291.26 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
254.37 million
Earnings per share
-0.036
Dividend per share
N/A
Year To Date Return
3.62%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies Ltd (ASX: VHT)
Latest News
Share Market News
Volpara share price lower on insider block trade news
Speculative
3 small cap ASX healthcare shares which could be destined for big things
Share Gainers
Why Freedom Foods, iSignthis, Volpara, & Western Areas shares zoomed higher today
Share Gainers
ALL ORDINARIES finishes lower Monday: 8 shares you missed
Share Gainers
Volpara share price surges higher following trading update
⏸️ Investing
Analysts share top ASX stock picks for FY20
Speculative
These exciting small cap ASX tech shares could be the stars of 2020
Speculative
Why I would add Althea and these small cap ASX healthcare shares to your watchlist
Speculative
3 exciting small cap ASX tech shares that could be destined for big things
Speculative
3 small cap ASX shares that could be long-term market beaters
Share Gainers
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
Speculative
These exciting small cap ASX tech shares could be stars of the future
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies Ltd
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
VHT Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 03 May 2024 | $1.15 | $0.01 | 0.88% | 1,347,641 | $1.15 | $1.15 | $1.14 |
| 02 May 2024 | $1.14 | $0.00 | 0.00% | 999,903 | $1.15 | $1.15 | $1.14 |
| 01 May 2024 | $1.14 | $-0.01 | -0.87% | 23,096 | $1.14 | $1.15 | $1.14 |
| 30 Apr 2024 | $1.15 | $0.01 | 0.88% | 4,997,892 | $1.14 | $1.15 | $1.14 |
| 29 Apr 2024 | $1.14 | $0.00 | 0.00% | 59,122 | $1.14 | $1.15 | $1.14 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 17 Aug 2023 | Mark Bouw | Issued | 450,000 | $585,000 |
Issue of options.
|
| 02 Jun 2023 | Teri Thomas | Sell | 3,577 | $2,546 |
On-market trade.
|
| 01 Jun 2023 | Teri Thomas | Buy | 75,280 | $57,213 |
Conversion of securities. As per announcement on 02-06-2023
|
| 01 Jun 2023 | Teri Thomas | Exercise | 75,280 | $57,213 |
Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Teri Thomas | Chief Executive OfficerManaging Director | Apr 2022 |
Teri joined the Board in October 2022. She has a
long history of executive management in healthcare IT ranging from strategy and operations to running global sales and marketing teams. This includes a 20-year career at Epic, a global leader in electronic health record (EHR) systems and other software solutions used by hospitals and healthcare organisations in the United States and internationally |
| Mr Craig Hadfield | Chief Financial OfficerJoint Company Secretary | Mar 2017 |
-
|
| Mr Fred Struve | General CounselJoint Company Secretary | Oct 2022 |
-
|
| Craig Hadfield | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Fred Struve | General CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| No Top 20 | 27,534,688 | 10.84% |
| Patagorang Pty Ltd | 18,467,848 | 7.27% |
| Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> | 16,213,561 | 6.38% |
| Citicorp Nominees Pty Limited | 11,830,450 | 4.66% |
| HSBC Custody Nominees (Australia) Limited | 8,187,911 | 3.22% |
| Custodial Services Limited <Beneficiaries Holding A/C> | 8,154,911 | 3.21% |
| Bnp Paribas Noms (Nz) Ltd <Drp> | 7,061,556 | 2.78% |
| Prof Sir Michael Brady | 6,619,075 | 2.61% |
| Mr Marcus Sarner | 5,980,404 | 2.35% |
| National Nominees Limited | 4,728,818 | 1.86% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient | 4,420,193 | 1.74% |
| Sir Martin Francis Wood | 3,004,655 | 1.18% |
| Lady Kathleen Audrey Wood | 3,004,654 | 1.18% |
| BNP Paribas Noms Pty Ltd <Drp> | 2,527,511 | 0.99% |
| Prof Martin Yaffe | 1,966,483 | 0.77% |
| Mr John Anthony Dell | 1,928,864 | 0.76% |
| BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited | 1,917,409 | 0.75% |
| Prof Nico Karssemeijer | 1,806,806 | 0.71% |
| Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> | 1,519,964 | 0.60% |
| RX HOUSE TRUST PTY LTD | 880,758 | 0.35% |
